Matches in Wikidata for { <http://www.wikidata.org/entity/Q92041329> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q92041329 description "article scientifique publié en 2020" @default.
- Q92041329 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q92041329 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92041329 description "scientific article published on 01 April 2020" @default.
- Q92041329 description "wetenschappelijk artikel" @default.
- Q92041329 description "наукова стаття, опублікована 1 квітня 2020" @default.
- Q92041329 name "[Efficacy and safety of oral pyrotinib in HER2 positive metastatic breast cancer: real-world practice]" @default.
- Q92041329 name "[Efficacy and safety of oral pyrotinib in HER2 positive metastatic breast cancer: real-world practice]" @default.
- Q92041329 type Item @default.
- Q92041329 label "[Efficacy and safety of oral pyrotinib in HER2 positive metastatic breast cancer: real-world practice]" @default.
- Q92041329 label "[Efficacy and safety of oral pyrotinib in HER2 positive metastatic breast cancer: real-world practice]" @default.
- Q92041329 prefLabel "[Efficacy and safety of oral pyrotinib in HER2 positive metastatic breast cancer: real-world practice]" @default.
- Q92041329 prefLabel "[Efficacy and safety of oral pyrotinib in HER2 positive metastatic breast cancer: real-world practice]" @default.
- Q92041329 P1433 Q92041329-A13529B5-3468-4332-BD9F-B3A95841E98C @default.
- Q92041329 P1476 Q92041329-0835F351-4507-4B22-91BA-1AC83EAEB8BC @default.
- Q92041329 P2093 Q92041329-2152BB08-0669-47C2-B6DE-B3C0CFF2F20E @default.
- Q92041329 P2093 Q92041329-48F514AE-B749-473B-B595-8296C242299D @default.
- Q92041329 P2093 Q92041329-4927E030-EF6C-43B3-B204-9D560F46FFF2 @default.
- Q92041329 P2093 Q92041329-5520CED6-78DC-416E-9437-AC263020E2FF @default.
- Q92041329 P2093 Q92041329-7199F0C6-AC4D-41BB-84CB-C8D44B85CCD7 @default.
- Q92041329 P2093 Q92041329-72BE7986-B6C2-47D2-8977-5048C68581DE @default.
- Q92041329 P2093 Q92041329-744881CC-77E3-446F-BC5E-9CB862823E60 @default.
- Q92041329 P2093 Q92041329-7BB5B2D3-EB19-489F-AC32-4B298D42190D @default.
- Q92041329 P2093 Q92041329-87D9ED2E-EE5F-4E74-8447-370693C10420 @default.
- Q92041329 P2093 Q92041329-A2A5E568-F3DD-4669-9715-B61CC66668BF @default.
- Q92041329 P2093 Q92041329-CD3585BF-DD0A-4AA8-870D-EA4D2641FB1F @default.
- Q92041329 P2093 Q92041329-F297539D-B520-4425-BB17-D55B89FCBCAE @default.
- Q92041329 P2093 Q92041329-F7D85EAC-E58D-4E36-9473-B1B21FFB2C24 @default.
- Q92041329 P304 Q92041329-5B12821A-64FF-4847-9FB9-E8DA6C74B451 @default.
- Q92041329 P31 Q92041329-95A3E342-3FD3-423E-8AFA-4202A3243C71 @default.
- Q92041329 P433 Q92041329-1EF95E45-A90D-4751-BEAB-09E4C7600FAB @default.
- Q92041329 P478 Q92041329-4588B77F-E422-4843-B09A-44D74E19022C @default.
- Q92041329 P577 Q92041329-D4B6DE69-8157-4861-9688-F2D16B9CDC4B @default.
- Q92041329 P698 Q92041329-4D1331C1-D5E5-4ABB-A915-D095AEAAE54A @default.
- Q92041329 P921 Q92041329-C62718A1-31D0-4D2C-8EA9-DD18F7950BE3 @default.
- Q92041329 P698 32306007 @default.
- Q92041329 P1433 Q15745363 @default.
- Q92041329 P1476 "[Efficacy and safety of oral pyrotinib in HER2 positive metastatic breast cancer: real-world practice]" @default.
- Q92041329 P2093 "D G Wan" @default.
- Q92041329 P2093 "G H Song" @default.
- Q92041329 P2093 "H F Jiang" @default.
- Q92041329 P2093 "H P Li" @default.
- Q92041329 P2093 "H Wang" @default.
- Q92041329 P2093 "L J DI" @default.
- Q92041329 P2093 "L Xu" @default.
- Q92041329 P2093 "M P Wang" @default.
- Q92041329 P2093 "R Ran" @default.
- Q92041329 P2093 "R Y Zhang" @default.
- Q92041329 P2093 "Y Li" @default.
- Q92041329 P2093 "Y Xiao" @default.
- Q92041329 P2093 "Y Yan" @default.
- Q92041329 P304 "254-260" @default.
- Q92041329 P31 Q13442814 @default.
- Q92041329 P433 "2" @default.
- Q92041329 P478 "52" @default.
- Q92041329 P577 "2020-04-01T00:00:00Z" @default.
- Q92041329 P698 "32306007" @default.
- Q92041329 P921 Q12859063 @default.